Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation

BACKGROUND: A study was undertaken to determine the impact of prior coronary revascularization (angioplasty, stent, or coronary artery bypass graft) on the risk of all‐cause mortality after neoadjuvant hormonal therapy (HT) for prostate cancer (PC) in men with a history of coronary artery disease (C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2011-01, Vol.117 (2), p.406-413
Hauptverfasser:	Nguyen, Paul L., Chen, Ming H., Goldhaber, Samuel Z., Martin, Neil E., Beard, Clair J., Dosoretz, Daniel E., Katin, Michael J., Ross, Rudi, Salenius, Sharon A., D'Amico, Anthony V
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - adverse effects androgen deprivation therapy Angioplasty - adverse effects Antineoplastic agents Biological and medical sciences Brachytherapy Cancer cardiovascular Cause of Death Chemotherapy Combined Modality Therapy Coronary Artery Bypass - adverse effects death Heart Failure - complications Historical account hormone therapy Humans Male males Medical sciences Mortality Myocardial infarction Myocardial Infarction - etiology Myocardial Infarction - surgery Neoadjuvant Therapy Pharmacology. Drug treatments prostate cancer Prostatic Neoplasms - complications Prostatic Neoplasms - drug therapy Prostatic Neoplasms - mortality Prostatic Neoplasms - radiotherapy revascularization Risk Stents Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!